Short-course (5-day) moxifloxacin versus 7-day levofloxacin therapy for treatment of acute exacerbations of chronic bronchitis

Today's Therapeutic Trends

Volumn 19, Issue 2, 2001, Pages 117-136

  Hautamaki, D ^a   Bruya, T ^a   Kureishi, A ^a   Warner, J ^a   Church, D ^a  

^a BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; MOXIFLOXACIN;

ABDOMINAL PAIN; ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIOLOGY; CARDIOTOXICITY; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DYSPEPSIA; DYSPNEA; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; VERTIGO; VOMITING; XEROSTOMIA;

EID: 0035006878     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)